Ikarian Capital, LLC Adjusts Stake in Avalo Therapeutics Inc
| TARS Stock | USD 55.15 0.22 0.40% |
Slightly above 54% of Tarsus Pharmaceuticals' investor base is interested to short. The analysis of overall sentiment of trading Tarsus Pharmaceuticals stock suggests that many investors are impartial at this time. Tarsus Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Tarsus Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Tarsus |
Recent Transaction Overview On September 30, 2024, Ikarian Capital, LLC made a significant adjustment to its investment in Avalo Therapeutic
Read at gurufocus.com
 |
Tarsus Pharmaceuticals Fundamental Analysis
We analyze Tarsus Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tarsus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tarsus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Tarsus Pharmaceuticals is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Tarsus Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tarsus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Tarsus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Tarsus Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Tarsus Pharmaceuticals Related Equities
| TVTX | Travere Therapeutics | 8.90 | ||||
| ABOS | Acumen Pharmaceuticals | 7.56 | ||||
| HOWL | Werewolf Therapeutics | 5.41 | ||||
| CNTA | Centessa Pharmaceuticals | 4.48 | ||||
| IKNA | Ikena Oncology | 2.50 | ||||
| ETON | Eton Pharmaceuticals | 2.23 | ||||
| STOK | Stoke Therapeutics | 2.18 | ||||
| NUVL | Nuvalent | 2.18 | ||||
| TRDA | Entrada Therapeutics | 0.98 | ||||
| GNFT | Genfit | 0.81 | ||||
| ELDN | Eledon Pharmaceuticals | 0.48 | ||||
| ALDX | Aldeyra | 0.60 | ||||
| PEPG | PepGen | 1.04 | ||||
| RLYB | Rallybio Corp | 1.04 | ||||
| GLUE | Monte Rosa | 1.14 | ||||
| TYRA | Tyra Biosciences | 1.21 | ||||
| DSGN | Design Therapeutics | 1.28 | ||||
| NUVB | Nuvation Bio | 2.63 | ||||
| PHVS | Pharvaris | 3.29 | ||||
| OPT | Opthea | 6.11 | ||||
| CNTB | Connect Biopharma | 12.32 |
Additional Tools for Tarsus Stock Analysis
When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.